Thrombopoietin Receptor Agonists Market Size

Thrombopoietin Receptor Agonist Market size was valued at USD 1.74 billion in 2023 and is likely to cross USD 3.95 billion by 2036, expanding at more than 6.5% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of thrombopoietin receptor agonist is estimated at USD 1.83 billion.

Immune thrombocytopenia purpura is a lethal disease where shortage of platelets could create complications. Thrombopoietin receptor agonists have been pivotal in managing the disease. In the recent times, pharmaceutical companies manufacturing drugs for rare diseases have received approval from European Medicines Agency and the United States Food and Drug Administration. Owing to these factors, the thrombopoietin receptor agonist market is expected to attain a significant CAGR during the forecast period